MISSIONPHARMA A/S: Financial statements 2013
CVR: 26902398
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
MISSIONPHARMA A/S (CVR 26902398) has filed annual accounts for 2013. In 2013, the company reported revenue of DKK 537,927,000 and a net result of DKK 44,083,000. The profit margin was 8.2%. Equity in the 2013 report amounted to DKK 124,385,000. The solvency ratio was 58.1%. The company had 45 employees in the financial year.
- Revenue
- DKK 537,927,000
- Gross Profit
- DKK 106,132,000
- Profit/Loss
- DKK 44,083,000
- Equity
- DKK 124,385,000
- Total Assets
- DKK 214,241,000
- Employees
- 45
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
MISSIONPHARMA A/S has published its interim report for the period May 1, 2012 – December 31, 2012.
As of March 15, 2013, Kim Erik Ginnerup is registered as adm. dir. of MISSIONPHARMA A/S.
As of March 15, 2013, Mikkel Mørkedal Wakefield has stepped down as adm. dir. of MISSIONPHARMA A/S.
About MISSIONPHARMA A/S
MISSIONPHARMA A/S is a Danish company of the type Aktieselskab based in Lynge, founded in 2002. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jean-Marc Pierre René Leccia and Edouard Marc Marie Favreau. The board consists of Eric Pierre Jean Muris (chair), Kim Erik Ginnerup, Ilona Maureen Fischer and Jean-Marc Pierre René Leccia. The company is owned by CFAO HEALTHCARE SA. The company has 67 employees (2026). In 2026, the company reported revenue of DKK 934,465,000 and a net result of DKK 120,205,000 compared with DKK 73,402,000 the year before. Equity in the 2026 report amounted to DKK 317,751,000.